Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Chapman

Showing results (851-860 of 1,011) with videos related to

Pageof 102
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 20, 2015
Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC)Ronald D Perrone, Jon Neville, Arlene B Chapman, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 30, 2012
Neuroimaging correlates of novel psychiatric disorders after pediatric traumatic brain injuryJeffrey E Max, Elisabeth A Wilde, Erin D Bigler, et al.
Regenerative Medicine|March 17, 2010
Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogrammingH Vaziri, K B Chapman, A Guigova, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2010
Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney diseaseVicente E Torres, Jared J Grantham, Arlene B Chapman, et al.
American Journal of Clinical Pathology|October 28, 2011
Detection of genomic abnormalities in multiple myeloma: the application of FISH analysis in combination with various plasma cell enrichment techniquesLuise Hartmann, Julie Sanford Biggerstaff, Douglas B Chapman, et al.
Kidney International|March 19, 2015
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceArlene B Chapman, Olivier Devuyst, Kai-Uwe Eckardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2021
Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study)Michael A Postow, Debra A Goldman, Alexander N Shoushtari, et al.
Journal of the American Heart Association|November 12, 2014
Large-scale gene-centric analysis identifies polymorphisms for resistant hypertensionVanessa Fontana, Caitrin W McDonough, Yan Gong, et al.
Current Hypertension Reviews|May 3, 2017
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD TrialsGodela M Brosnahan, Kaleab Z Abebe, Frederic F Rahbari-Oskoui, et al.
Ophthalmology|July 16, 2017
Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous ChorioretinopathyJasmine H Francis, Larissa A Habib, David H Abramson, et al.
Pageof 102

Showing results (851-860 of 1,011) with videos related to

Sort By:
Pageof 102
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 20, 2015
Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC)Ronald D Perrone, Jon Neville, Arlene B Chapman, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 30, 2012
Neuroimaging correlates of novel psychiatric disorders after pediatric traumatic brain injuryJeffrey E Max, Elisabeth A Wilde, Erin D Bigler, et al.
Regenerative Medicine|March 17, 2010
Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogrammingH Vaziri, K B Chapman, A Guigova, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2010
Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney diseaseVicente E Torres, Jared J Grantham, Arlene B Chapman, et al.
American Journal of Clinical Pathology|October 28, 2011
Detection of genomic abnormalities in multiple myeloma: the application of FISH analysis in combination with various plasma cell enrichment techniquesLuise Hartmann, Julie Sanford Biggerstaff, Douglas B Chapman, et al.
Kidney International|March 19, 2015
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceArlene B Chapman, Olivier Devuyst, Kai-Uwe Eckardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2021
Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study)Michael A Postow, Debra A Goldman, Alexander N Shoushtari, et al.
Journal of the American Heart Association|November 12, 2014
Large-scale gene-centric analysis identifies polymorphisms for resistant hypertensionVanessa Fontana, Caitrin W McDonough, Yan Gong, et al.
Current Hypertension Reviews|May 3, 2017
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD TrialsGodela M Brosnahan, Kaleab Z Abebe, Frederic F Rahbari-Oskoui, et al.
Ophthalmology|July 16, 2017
Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous ChorioretinopathyJasmine H Francis, Larissa A Habib, David H Abramson, et al.
Pageof 102